Clinical Endocrine Oncology
2nd Edition
Will be published approx. on 15. April 2008
Book
Hardback
664 pages
978-1-4051-4584-8 (ISBN)
Description
A truly comprehensive reference for the management of patients with endocrine cancer
The new edition of Clinical Endocrine Oncology has been fully revised and extended making it the most comprehensive and up-to-date reference available. Written and edited by leading international experts in the field, it sets the standard in multidisciplinary care for patients with endocrine tumors.
The book provides specific and detailed guidance on the basic, clinical, investigative and therapeutic processes required for the thorough evaluation of a patient with a tumor in an endocrine organ. The eighty-four chapters are arranged in seven parts:
* Endocrine Oncology and Therapeutic Options
* Thyroid and Parathyroid Tumors
* Pituitary and Hypothalamic Lesions
* Adrenal and Gonadal Tumors
* Neuroendocrine Tumors and the Clinical Syndromes
* Medical Syndromes and Endocrine Neoplasia
* Endocrine-responsive Tumors and Female Reproductive Hormone Therapy.
This authoritative and practical text will be an invaluable resource for all those working in the field, including endocrinologists, medical oncologists, surgeons, radiation therapists, interventional radiologists, specialist nurses, and clinical scientists.
John A.H. Wass is joined in this edition by a new editor, Ian D. Hay, Professor of Medicine and Endocrinology Research at the Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Reviews / Votes
"I recommend the book for physicians who see diagnose and treat patients with endocrine tumors It provides a broad strong base of knowledge and a good foundation for further investigation of the treatment options for these tumors." (New England Journal of Medicine, April 2009) "The new edition of Clinical Endocrine Oncology has been fully revised and extended making it the most comprehensive and up-to-date reference available. Written and edited by leading international experts in the field, it sets the standard in multidisciplinary care for patients with endocrine tumors. This authoritative and practical text will be an invaluable resource for all those working in the field ... .Because so much has changed since the first edition was published 11 years ago, a second edition is warranted." (Doody's Book Reviews, October 2008)More details
Product info
GB
Edition
2., Auflage
Language
English
Place of publication
Hoboken
United Kingdom
Publishing group
John Wiley and Sons Ltd
Target group
Professional and scholarly
Endocrinologists, including trainees and residents, oncologists, including trainees and residents
Edition type
New edition
Dimensions
Height: 28.4 cm
Width: 22.6 cm
Thickness: 3.6 cm
Weight
2136 gr
ISBN-13
978-1-4051-4584-8 (9781405145848)
Schweitzer Classification
Other editions
Additional editions
Ian D. Hay | John A. H. Wass
Clinical Endocrine Oncology
E-Book
01/2009
2nd Edition
Wiley-Blackwell
€269.99
Available for download
Previous edition
Richard Sheaves | Paul Jenkins | John A. Wass
Clinical Endocrine Oncology
Book
02/1997
1st Edition
Blackwell Science Ltd
€189.00
Article exhausted; check for reprint
Persons
Ian D. Hay, Professor of Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA. A Glasgow graduate, Professor Hay has spent the majority of his career in the USA, winning the Randall G. Sprague Award for Outstanding Achievement as a Subspecialty Trainee in Endocrinology from the Mayo Clinic in 1981. He has been recognised with thirteen awards throughout his career, the latest one being the Prix de la Journee de Medecine Nucleaire from the l'Institut Gustave Roussy, Villejuif, France in 1997. He is also a contributor to Williams' Textbook of Endocrinology.
John A.H. Wass, Professor of Endocrinology, The Oxford Centre for Diabetes, Endocrinology & Metabolism, Oxford, UK. Current President of the European Federation of Endocrine Societies and President of the Society for Endocrinology (UK). Co-Editor of The Oxford Textbook of Endocrinology and Diabetes (published 2002) and The Oxford Handbook of Endocrinology and Diabetes (published August 2002).
Content
List of Contributors.
Foreword.
Preface.
Part I: Endocrine Oncology and Therapeutic Options.
1. Structure and Development of the Endocrine System.
2. Epidemiology of Endocrine Tumors.
3. Inherited Cancers, Genes and Chromosomes.
4. Hormones, Growth Factors and Tumor Growth.
5. Genetic Counselling and Clinical Cancer Genetics.
6. Prospects for Gene Therapy for Endocrine Malignancies.
7. Tumor Targeting.
8. Techniques in Radiation Medicine.
9. Interventional Radiology.
10. Surgical Management of Endocrine Tumors.
11. Endocrine Tumor Markers.
12. General Management of Cancer Patients.
Part II: Thyroid and Parathyroid Tumors.
13. The Assessment of Thyroid Neoplasia.
14. Thyroid and Parathyroid Imaging.
15. Pathogenesis of Thyroid Cancer.
16. Papillary Thyroid Cancer.
17. Follicular Thyroid Carcinoma.
18. Anaplastic Thyroid Carcinoma.
19. Thyroid Lymphoma.
20. Radiation Induced Thyroid Tumors.
21. Parathyroid Adenomas and Hyperplasia.
22. Parathyroid Carcinoma.
Part III: Pituitary and Hypothalamic Lesions.
23. Molecular Pathogenesis of Pituitary Adenomas.
24. Functional Assessment of the Pituitary.
25. Imaging of the Pituitary and Hypothalamus.
26. Pathology of Tumors of the Pituitary.
27. Surgery for Pituitary Tumors.
28. Pituitary Radiotherapy.
29. Prolactinomas.
30. Acromegaly.
31. Cushing's Disease.
32. Non Functioning Pituitary Adenomas and Gonadotropinomas.
33. Thyrotropinomas.
34. Pituitary Carcinoma.
35. Pituitary Incidentalomas.
36. Craniopharyngioma.
37. Benign Cysts: Rathke's Cysts, Mucoceles, Arachnoid Cysts, and Dermoid and Epidermoid Cysts.
38. Hypothalamic Hamartomas and Gangliocytomas.
39. Cranial Ependymoma.
40. Perisellar Tumors Including Chordoma, Optic Nerve Glioma, Meningioma, Hemangiopericytoma and Glomus Tumors.
41. Pineal Tumors: Germinomas and Non Germinomatous Germ Cell Tumors.
42. Cavernous Sinus Hemangiomas.
43. Langerhans' Cell Histiocytosis.
44. Pituitary and Hypothalamic Sarcoidosis.
Part IV: Adrenal and Gonadal Tumors.
45. Imaging of the Adrenal Glands.
46. Pheochromocytoma.
47. Peripheral Neuroblastic Tumors.
48. Primary Hyperaldosteronism.
49. Adrenal Causes of Cushing's Syndrome.
50. Adrenal Incidentalomas.
51. Androgen Secreting Tumors.
52. Functional Ovarian Tumors.
53. Endocrine Aspects of Ovarian Cancer.
54. Testicular Germ-cell Cancers.
55. Neoplasia and Intersex States.
56. Gestational Trophoblastic Neoplasia.
Part V: Neuroendocrine Tumors and the Clinical Syndromes.
57. Classification of Neuroendocrine Tumors.
58. Imaging of Gastrointestinal Neuroendocrine Tumors.
59. Insulinomas and Hypoglycemia.
60. Gastrinoma (Zollinger-Ellison Syndrome).
61. VIPomas.
62. Glucagonomas.
63. Somatostatinoma.
64. Lung and Thymic Neuroendocrine Tumors.
65. Carcinoid Syndrome.
66. Appendiceal and Hindgut Carcinoids.
67. Chemotherapy for Neuroendocrine Tumors.
Part VI: Medical Syndromes and Endocrine Neoplasia.
68. Multiple Endocrine Neoplasia Type 1 (MEN 1).
69. Medullary Thyroid Carcinoma and Associated Multiple Endocrine Neoplasia Type 2.
70. von Hippel-Lindau Disease.
71. Neurofibromatosis Type 1.
72. Carney Complex.
73. McCune-Albright Syndrome.
74. Cowden Syndrome.
75. Paraneoplastic Syndromes.
76. Syndrome of Inappropriate Antidiuretic Hormone Secretion.
77. Hypercalcemia of Malignancy.
78. Syndrome of Ectopic ACTH Secretion.
79. Insulin-like Growth Factors and Tumor Hypoglycemia.
80. Metastatic and Other Extraneous Neoplasms in Endocrine Organs.
81. Endocrine Late-Effects of Cancer Therapy.
Part VII: Endocrine-responsive Tumors and the Effects of Female Reproductive Hormone Therapy.
82. Endocrine-responsive Tumors: Prostate Cancer.
83. Endocrine Therapy in Breast Cancer Management.
84. Female Reproductive Hormone Therapy: Risks and Benefits.
Index